- Home
- Labeler Index
- Takeda Pharmaceuticals America, Inc.
- 47783-645
- NDC Crossover: 47783-645 Takhzyro
NDC Crossover 47783-645 Takhzyro
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Lanadelumab
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 47783-645 – Takhzyro, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Takhzyro
- OR Generic name: Lanadelumab-flyo
- AND the same Administration Route: subcutaneous
- OR Dosage Form: solution
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
47783-644 | Takhzyro | Lanadelumab-flyo | Injection, Solution | Subcutaneous | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |
47783-646 | Takhzyro | Lanadelumab-flyo | Solution | Subcutaneous | Takeda Pharmaceuticals America, Inc. | Human Prescription Drug |